Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC45999Phentolamine-d4 (hydrochloride)CAS: 1346599-65-2纯度: >99.00%
An internal standard for the quantification of phentolamine
- GC46131Diazoxide-d3CAS: 1432063-51-8纯度: >99.00%
An internal standard for the quantification of diazoxide
- GC46134Dityrosine (hydrochloride)CAS: 2716849-01-1纯度: >95.00%
A neuropeptide with diverse biological activities
- GC46202Phenoxybenzamine-d5 (hydrochloride)CAS: 1329838-45-0纯度: >98.00%
An internal standard for the quantification of phenoxybenzamine
- GC46235Vitamin K1-d7CAS: 1233937-39-7纯度: >99.00%
An internal standard for the quantification of vitamin K 1
- GC462417-keto Cholesterol-d7CAS: 127684-08-6纯度: >99.00%
An internal standard for the quantification of 7-keto cholesterol
- GC4624324-dehydro Cholesterol-d6CAS: 1246298-67-8纯度: >99.00%
An internal standard for the quantification of 24-dehydro cholesterol
- GC46273(±)-Atenolol-d7CAS: 1202864-50-3纯度: >99.00%
An internal standard for the quantification of (±)-atenolol
- GC46289(±)-Felodipine-d5CAS: 1242281-38-4纯度: >99.00%
An internal standard for the quantification of felodipine
- GC46304(±)-Nebivolol-d4 (hydrochloride)CAS: 2701283-32-9纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46307(±)-Propranolol-d7CAS: 344298-99-3纯度: >99.00%
An internal standard for the quantification of propranolol
- GC46312(±)-Verapamil-d3 (hydrochloride)CAS: 2714485-49-9纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46336(E)-GuggulsteroneCAS: 39025-24-6纯度: >98.00% / >98.50%
(E)-Guggulsterone是一种具有口服活性，能够调节胆固醇/胆汁酸代谢的法尼醇X受体（FXR）拮抗剂，IC 50 值为24.06μM。
- GC46362[Sar9, Met(O2)11]-Substance P (trifluoroacetate salt)纯度: >95.00%
A neuropeptide with diverse biological activities
- GC463871,3,7-Trimethyluric Acid-d9CAS: 117490-42-3纯度: >99.00%
An internal standard for the quantification of 1,3,7-trimethyluric acid
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC45903 | Quazinone | 70018-51-8 | >98.00% | |
A PDE3 inhibitor | ||||
| GC45999 | Phentolamine-d4 (hydrochloride) | 1346599-65-2 | >99.00% | |
An internal standard for the quantification of phentolamine | ||||
| GC46126 | Debrisoquin (hemisulfate) | 581-88-4 | >98.00% | |
A post-ganglionic sympathetic blocker | ||||
| GC46131 | Diazoxide-d3 | 1432063-51-8 | >99.00% | |
An internal standard for the quantification of diazoxide | ||||
| GC46134 | Dityrosine (hydrochloride) | 2716849-01-1 | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46137 | Emestrin | 97816-62-1 | >95.00% | |
A mycotoxin | ||||
| GC46155 | H-Ile-Pro-Pro-OH (trifluoroacetate salt) | - | >95.00% | |
具有多种生物活性的神经肽 | ||||
| GC46170 | Methylspinazarin | 41768-12-1 | >95.00% | |
A bacterial metabolite and COMT inhibitor | ||||
| GC46175 | MOTS-c (human) (trifluoroacetate salt) | - | >95.00% | |
具有多种生物活性的神经肽 | ||||
| GC46202 | Phenoxybenzamine-d5 (hydrochloride) | 1329838-45-0 | >98.00% | |
An internal standard for the quantification of phenoxybenzamine | ||||
| GC46233 | Trandolaprilat (hydrate) | 951393-55-8 | >95.00% | |
An ACE inhibitor | ||||
| GC46235 | Vitamin K1-d7 | 1233937-39-7 | >99.00% | |
An internal standard for the quantification of vitamin K 1 | ||||
| GC46241 | 7-keto Cholesterol-d7 | 127684-08-6 | >99.00% | |
An internal standard for the quantification of 7-keto cholesterol | ||||
| GC46243 | 24-dehydro Cholesterol-d6 | 1246298-67-8 | >99.00% | |
An internal standard for the quantification of 24-dehydro cholesterol | ||||
| GC46260 | (±)17(18)-EpETE | - | >90.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46273 | (±)-Atenolol-d7 | 1202864-50-3 | >99.00% | |
An internal standard for the quantification of (±)-atenolol | ||||
| GC46289 | (±)-Felodipine-d5 | 1242281-38-4 | >99.00% | |
An internal standard for the quantification of felodipine | ||||
| GC46304 | (±)-Nebivolol-d4 (hydrochloride) | 2701283-32-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46307 | (±)-Propranolol-d7 | 344298-99-3 | >99.00% | |
An internal standard for the quantification of propranolol | ||||
| GC46312 | (±)-Verapamil-d3 (hydrochloride) | 2714485-49-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46336 | (E)-Guggulsterone | 39025-24-6 | >98.00% / >98.50% | |
(E)-Guggulsterone是一种具有口服活性，能够调节胆固醇/胆汁酸代谢的法尼醇X受体（FXR）拮抗剂，IC 50 值为24.06μM。 | ||||
| GC46346 | (S)-(+)-Clopidogrel-d3 (sulfate) | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46362 | [Sar9, Met(O2)11]-Substance P (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46387 | 1,3,7-Trimethyluric Acid-d9 | 117490-42-3 | >99.00% | |
An internal standard for the quantification of 1,3,7-trimethyluric acid | ||||